Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Effects of BCc1 nanoparticle and its mixture with doxorubicin on survival of murine 4T1 tumor model.

Hafizi M, Soleimani M, Noorian S, Kalanaky S, Fakharzadeh S, Tavakolpoor Saleh N, Nazaran MH, Akbari ME.

Onco Targets Ther. 2019 Jun 18;12:4691-4701. doi: 10.2147/OTT.S200446. eCollection 2019.

2.

DIBc, a nanochelating-based nano metal-organic framework, shows anti-diabetic effects in high-fat diet and streptozotocin-induced diabetic rats.

Fakharzadeh S, Kalanaky S, Hafizi M, Nazaran MH, Zardooz H.

Int J Nanomedicine. 2019 Mar 27;14:2145-2156. doi: 10.2147/IJN.S196050. eCollection 2019.

3.

A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients.

Hafizi M, Kalanaky S, Moaiery H, Khayamzadeh M, Noorian S, Kaveh V, Gharib B, Foudazi H, Razavi M, Jenabian A, Salimi S, Sereshki MMA, Mirzaei HR, Zarghi A, Fakharzadeh S, Nazaran MH, Akbari ME.

J Nanobiotechnology. 2019 Apr 10;17(1):52. doi: 10.1186/s12951-019-0484-0.

4.

Anti-hyperalgesia effect of nanchelating based nano particle, RAc1, can be mediated via liver hepcidin expression modulation during persistent inflammation.

Nazemian V, Kalanaky S, Manaheji H, Houshmandi E, Mohammadi M, Zaringhalam J, Mirjafai S.

Int Immunopharmacol. 2019 Apr;69:337-346. doi: 10.1016/j.intimp.2019.02.003. Epub 2019 Feb 15.

PMID:
30776642
5.

TLc-A, the leading nanochelating-based nanochelator, reduces iron overload in vitro and in vivo.

Kalanaky S, Hafizi M, Safari S, Mousavizadeh K, Kabiri M, Farsinejad A, Fakharzadeh S, Nazaran MH.

Int J Hematol. 2016 Mar;103(3):274-82. doi: 10.1007/s12185-015-1932-8. Epub 2016 Feb 1.

PMID:
26830968
6.

BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo.

Kalanaky S, Hafizi M, Fakharzadeh S, Vasei M, Langroudi L, Janzamin E, Hashemi SM, Khayamzadeh M, Soleimani M, Akbari ME, Nazaran MH.

Drug Des Devel Ther. 2015 Dec 30;10:59-70. doi: 10.2147/DDDT.S89694. eCollection 2016.

7.

Nanochelating based nanocomplex, GFc7, improves quality and quantity of human mesenchymal stem cells during in vitro expansion.

Hafizi M, Hajarizadeh A, Atashi A, Kalanaky S, Fakharzadeh S, Masoumi Z, Nazaran MH, Soleimani M.

Stem Cell Res Ther. 2015 Nov 23;6:226. doi: 10.1186/s13287-015-0216-9.

8.

Neuroprotective effects of three different sizes nanochelating based nano complexes in MPP(+) induced neurotoxicity.

Maghsoudi A, Fakharzadeh S, Hafizi M, Abbasi M, Kohram F, Sardab S, Tahzibi A, Kalanaky S, Nazaran MH.

Apoptosis. 2015 Mar;20(3):298-309. doi: 10.1007/s10495-014-1069-x.

PMID:
25451011
9.

The therapeutic effects of MSc1 nanocomplex, synthesized by nanochelating technology, on experimental autoimmune encephalomyelitic C57/BL6 mice.

Fakharzadeh S, Sahraian MA, Hafizi M, Kalanaky S, Masoumi Z, Mahdavi M, Kamalian N, Minagar A, Nazaran MH.

Int J Nanomedicine. 2014 Aug 11;9:3841-53. doi: 10.2147/IJN.S64630. eCollection 2014.

10.

The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine.

Fakharzadeh S, Kalanaky S, Hafizi M, Goya MM, Masoumi Z, Namaki S, Shakeri N, Abbasi M, Mahdavi M, Nazaran MH.

Vaccine. 2013 May 24;31(22):2591-7. doi: 10.1016/j.vaccine.2013.03.030. Epub 2013 Apr 10.

PMID:
23583463

Supplemental Content

Loading ...
Support Center